Results 131 to 140 of about 28,637 (186)

Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2). [PDF]

open access: yesAm Heart J
Navas-Acien A   +18 more
europepmc   +1 more source

Chelation Therapy in Iron Poisoning [PDF]

open access: yesJournal of Toxicology: Clinical Toxicology, 1982
openaire   +2 more sources

Chelation Therapy of Atherosclerosis

Drug Intelligence & Clinical Pharmacy, 1984
Chelation therapy with intravenous injections of edetate disodium is being promoted to the public as a nonsurgical means to treat coronary or other arterial atherosclerosis. The rationale for use, clinical efficacy, and safety are reviewed. Acceptable evidence supporting chelation therapy for atherosclerotic vascular disease is lacking.
Larry K Golightly
exaly   +3 more sources

Combined iron chelation therapy [PDF]

open access: yesAnnals of the New York Academy of Sciences, 2010
Patients with thalassemia major accumulate body iron over time as a consequence of continuous red blood cell transfusions which cause hepatic, endocrine, and cardiac complications. Despite the availability of three iron chelators, some patients fail to respond adequately to monotherapy with any of them. Combination therapy, consisting in the use of two
Galanello Renzo   +5 more
openaire   +3 more sources

Kill or cure: Misuse of chelation therapy for human diseases [PDF]

open access: yesCoordination Chemistry Reviews, 2015
Chelation therapy is a consolidated medical procedure used primarily to reduce the toxic effects of metal ions on human tissues. Its application spans a broad spectrum of disorders, ranging from acute metal intoxication to genetic metal-overload. The use
Maria Antonietta Zoroddu   +2 more
exaly   +4 more sources

Chelation therapy in cardiovascular disease: an update [PDF]

open access: yesExpert Review of Clinical Pharmacology, 2017
INTRODUCTION: The off-label use of chelation therapy (disodium edetate or EDTA) for prevention of cardiovascular disease (CVD) is widespread, despite the lack of convincing evidence for efficacy or approval from the Food and Drug Administration.
, , Farouk Mookadam
exaly   +2 more sources

Home - About - Disclaimer - Privacy